Construction of ELISA system to quantify human ST2 protein in sera of patients

Citation
K. Kuroiwa et al., Construction of ELISA system to quantify human ST2 protein in sera of patients, HYBRIDOMA, 19(2), 2000, pp. 151-159
Citations number
24
Categorie Soggetti
Immunology
Journal title
HYBRIDOMA
ISSN journal
0272457X → ACNP
Volume
19
Issue
2
Year of publication
2000
Pages
151 - 159
Database
ISI
SICI code
0272-457X(200004)19:2<151:COESTQ>2.0.ZU;2-B
Abstract
The human ST2 gene can be specifically induced by growth stimulation in fib roblastic cells, and can also be induced by antigen stimulation in Th2 cell s. The gene encodes a soluble secreted protein, ST2, and a transmembrane pr otein, ST2L, which are closely related to the interleukin-l receptor. To ga in insight into the biological roles of the ST2 gene, three monoclonal anti bodies (MAbs) against human ST2 gene products were obtained. To obtain thes e antibodies, immunization was carried out using two different immunogens: purified soluble human ST2 protein (hST2), and COS7 cells, which express th e extracellular portion of human ST2L, 2A5 and FB9 MAbs were derived from t he immunization with soluble hST2, and HB12 was derived from the COS7 cell immunization. All three antibodies were shown to detect native forms of the human ST2 gene products by immunoprecipitation, flow cytometry, and enzyme -linked immunosorbent assay (ELISA). In the competitive ELISA using biotiny lated and nonlabelled MAbs, neither FB9 nor HB12 affected the binding of 2A 5 to ST2 gene products. Based on this result, we constructed a sandwich ELI SA system using 2A5 and FB9 to measure the concentration of soluble hST2 in sera. The ELISA, combined with the flow cytometry using these antibodies, will be a useful tool for elucidating the functions of human ST2 gene produ cts in individuals.